Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4

Published:2017-11-07 Issue:2 Volume:25 Page:134-143
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Camus G.¹^ORCID,Han B.¹,Asselah T.²,Hsieh D.¹,Dvory-Sobol H.¹,Lu J.¹,Svarovskaia E.¹,Martin R.¹,Parhy B.¹,Miller M. D.¹,Brainard D. M.¹,Kersey K.¹,Abergel A.³,Mo H.¹

Affiliation:

1. Gilead Sciences, Inc.; Foster City CA USA

2. Department of Hepatology; Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris; Université Paris-Diderot and INSERM UMR1149; Clichy France

3. UMR CNRS 6284; Department of Hepatology and Gastroenterology; Centre Hospitalier Universitaire Estaing; Université d'Auvergne; Clermont-Ferrand France

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12795/fullpdf

Reference27 articles.

1. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011

2. Clinical outcomes after transfusion-associated hepatitis C;Tong;N Engl J Med,1995

3. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6;Nguyen;Clin Gastroenterol Hepatol,2005

4. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource;Smith;Hepatology,2014

5. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses;Welzel;J Hepatol,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

2. Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies;Journal of Hepatocellular Carcinoma;2023-09

3. Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial;The Lancet Gastroenterology & Hepatology;2022-06

4. Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial;The Lancet Gastroenterology & Hepatology;2022-06

5. The Emergence of Hepatitis C Virus Genotype 4d Among Human Immunodeficiency Virus–Infected Patients in Mexico City: A Molecular Epidemiological Study;Sexually Transmitted Diseases;2022-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3